** Mayne Pharma climbs as much as 11.74% to A$4.950; biggest intraday pct gain since Aug. 23
** MYX considering buyout with Jefferies looking for potential suitors, media report says
** Co confirms Jefferies is its financial adviser and is assisting with strategies to maximize shareholder value
** Mayne did not provide any further information to Reuters
** Stock set for third consecutive sessions of gains; top gainer on ASX All Ordinaries index
** MYX down 23.6% YTD
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.